FDA — authorised 29 September 2000
- Marketing authorisation holder: ALPHARMA US PHARMS
- Status: approved
🇺🇸 Propadrine in United States
FDA authorised Propadrine on 29 September 2000
Marketing authorisation
Propadrine in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Metabolic approved in United States
Frequently asked questions
Is Propadrine approved in United States?
Yes. FDA authorised it on 29 September 2000.
Who is the marketing authorisation holder for Propadrine in United States?
ALPHARMA US PHARMS holds the US marketing authorisation.